Future Farm Tech: A Portfolio Approach To Burgeoning Cannabis Industry
March 8th, 2018
Exclusive, News, Top News
The nascent cannabis industry is poised to exceed $50 billion in annual revenue over the coming years, according to Cowen & Co., driven by the legalization of adult-use cannabis across several states. In Canada, Deloitte believes that the market could exceed C$22.6 billion following the legalization of adult-use cannabis nationwide. Investors have many options when investing in the market, ranging from licensed producers to ancillary service providers.
Future Farm Technologies Inc. (CSE: FFT) (OTCQB: FFRMF) recently moved to uplist to the OTCQX exchange following its joint venture with TCG Investments to acquire an economic interest in five Puerto Rico-based medical dispensary licenses and its acquisition of three licenses from the State of Maine for the cultivation of industrial hemp. These developments translate to a highly transparent company with exposure to both cannabis and hemp markets.
Uplisting to the OTCQX
Future Farm recently announced that its board of directors approved its application to uplist from the OTCQB to the OTCQX International, the Premier Tier of the OTC Markets. At the same time, the company engaged a sponsoring brokerage and counsel to serve as its Designated Advisor for Disclosure to meet the listing requirements. These actions should help increase transparency for investors.
“Uplisting to the OTCQX is an activity we have planned as part of our corporate strategy for some time,” said Future Farm CEO Bill Gildea in the press release announcing the uplisting. “We are confident that the wider visibility amongst the investment community with strengthen stockholder value and enable us to continue on the path of accomplishing our corporate goals.”
Many investors have limitations when it comes to investing in over-the-counter companies. In particular, many institutional investors are unable to invest in companies that have limited disclosure requirements. An OTCQX International listing could open the door to these investors and help broaden the company’s shareholder base.
Finally, the move could set the stage for a future uplisting to a national exchange like the NYSE or NASDAQ. While there are few cannabis companies listed on these exchanges at the moment, possibly due to the federal prohibition of cannabis, future changes to the regulatory environment could open up the door. Companies that are already adhering to OTCQX International standards could have an easier time meeting the more stringent requirements.
A Portfolio Based Approach
Future Farm Technologies recently announced that it closed on its previously announced joint venture with TGC Investments LLC, which owns the Clinica Verde brand of medical cannabis dispensaries in Puerto Rico. Future Farm announced on March 7th that it has signed the first of five leases for their Clinica Verde branded Puerto Rico dispensaries. The company expects to sign two more leases in the next thirty days with the additional two leases to follow soon after.
Puerto Rico has legalized medical marijuana for over a dozen medical conditions, including Alzheimer’s, cancer, Lou Gehrig’s disease, Parkinson’s disease, rheumatoid arthritis, Crohn’s disease, epilepsy, and others. In October 2017, the government approved a rule that would enable patients to go to any open clinic, regardless of the dispensary that they had been assigned, which opens the door to new cannabis dispensaries.
In addition to cannabis, the company recently announced that it received three licenses from the State of Maine for the cultivation of industrial hemp. The move comes shortly after the company signed a lease for an initial 12,960 sq. ft. grow area in a 60,000 sq. ft. building with an option to expand or purchase the building. Management plans to germinate 250,000 hemp seeds over the next few months and has the option to expand from 100 to 1,000 acres.
The company’s focus is on cultivating feminized seeds that contain 0.03% of less THC while averaging 15% CBD content. Once harvested, the hemp will be dried and refined using the company’s high output oil processing equipment, creating both CBD oil and high value isolate for making edibles, creams, and lotions. Management believes that the market for CBD is poised to rapidly expand following the FDA’s decision on GW Pharma’s Epidiolex®.
In addition to these retail and hemp projects, the company is ramping up its cannabis assets. The company purchased a building in Rhode Island to cultivate and sell cannabis, as well as an operating greenhouse in Florida that’s generating $3 million in revenue and $500 in EBITDA while it applies for its cannabis license in the state. Management also signed a letter of intent to purchase a 51% stake in Attleboro Massachusetts to cultivate and sell cannabis.
Finally, the company formed a joint venture with Israeli Agriscience, a leader in the development of cannabis clones in Canada and California, to provide exposure to the research and development side of the industry.
Future Farm Technologies Inc. (CSE: FFT) (OTCQB: FFRMF) represents a compelling investment opportunity in the burgeoning cannabis industry. After deciding to uplist to the OTCQX, the company plans to offer investors greater transparency in a bid to broaden its shareholder base and ultimately generate greater shareholder value. At the same time, the company’s dual focus on cannabis and hemp positions it to take advantage of both areas of the rapidly growing cannabis industry.
For more information, visit the company’s website at www.futurefarmtech.com.
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please see our disclaimer below and follow the link to view our full disclosure outlining compensation: https://www.cannabisfn.com/legal-disclaimer/
Follow Us on Social Media
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.